Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings

Rocket Lab stock slips after COO’s $7.3 million sale filing; RKLB focus shifts to earnings

New York, Jan 7, 2026, 16:55 EST — After-hours

  • Rocket Lab shares fell 2.2% in regular trade after an executive stock sale disclosure
  • SEC filing showed the COO sold 100,000 shares under a pre-set trading plan
  • Investors now eye the next earnings update and any Neutron timeline signals

Rocket Lab Corp shares closed down 2.2% at $84.16 on Wednesday, after swinging between $81.85 and $85.96 as investors digested an insider sale after a sharp run-up earlier this week. StockAnalysis

The pullback matters because Rocket Lab has become a crowded trade in space-and-defense stocks, where price moves have been fast and explanations thin. After a big early-January jump, traders have been quick to treat insider selling as a check on momentum, even when it is routine.

A filing with the U.S. Securities and Exchange Commission showed Chief Operating Officer Frank Klein sold 100,000 shares on Jan. 2 at weighted average prices from $67.61 to $75.80, for proceeds of about $7.3 million. The filing said the sales were made under a Rule 10b5-1 plan — a pre-arranged trading plan companies use to reduce the risk of trading on inside information — and that Klein held 1,169,487 shares after the transactions. Securities and Exchange Commission

The broader tape was mixed. The S&P 500 slipped 0.3% and the Dow fell 0.9% on Wednesday, while the Nasdaq edged higher, leaving some high-beta names without much index help. AP News

Rocket Lab’s stock has been buoyed in recent weeks by defense-related optimism, including a Space Development Agency award the company disclosed in December. In an 8-K, Rocket Lab said the SDA contract has a total value of $816 million, including a $806 million base amount and options of about $10 million, with final delivery of the satellites expected in 2029. Securities and Exchange Commission

Still, there’s a simple risk case: insider selling can persist, and contract work and rocket development do not always land on clean schedules. Any slip in major program milestones — or signs costs are rising faster than revenue — can hit a stock that has been trading near recent highs.

What’s next is the calendar. Rocket Lab is expected to report results on Feb. 26, according to Nasdaq’s earnings schedule, and investors will listen for updates on margins, backlog conversion and any shifts in timelines for its next-generation Neutron rocket. Nasdaq

Stock Market Today

  • SGX securities daily average value for 2025 up 21%, highest since 2010
    January 9, 2026, 5:12 AM EST. Singapore Exchange reported a 29% year-on-year jump in December turnover value to S$25.8 billion as momentum in equities persisted. The securities daily average value (SDAV) for 2025 rose 21% to S$1.5 billion, the highest since 2010. The Straits Times Index (STI) closed at a record 4,655.38 on Dec 30, lifting 2025 total returns to 22.7% (28.8% with reinvested dividends), outpacing most ASEAN peers. Derivatives volumes reached a 2025 record, up 10% to 329 million contracts, while broader FX futures hit 79.3 million for the year. Retail participation in cash equities rose to a four-year high; institutions net-purchased S$415 million in small- and mid-cap stocks in 2025. STI constituents accounted for about 80% of SGX trading value, led by DBS (16%), UOB and Singtel (7%), OCBC (6%).
Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes
Previous Story

Strategy Inc stock rises after MSCI drops plan to kick bitcoin-treasury firms out of indexes

Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus
Next Story

Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus

Go toTop